Rhian M Touyz Rhian M Touyz BSc(Hons), MSc(Med), MBBCh, PhD, FRCP, FRSE, FMedSci, FAHA, FESC, FCAHS. Dr Touyz, a cardiovascular clinician-scientist, is Director of the Institute of Cardiovascular & Medical Sciences (ICAMS) and British Heart Foundation (BHF) Chair and Professor of Cardiovascular Medicine, University of Glasgow, UK. She also directs the BHF Centre of Research Excellence in Vascular Science and Medicine and is consultant (attending physician) in the Blood Pressure Unit, Queen Elizabeth University Hospital. Her clinical work focuses on cardiovascular risk and patients with complex hypertension. Dr Touyz received her BSc(Hons)(1980), MBBCh(1984), MSc(1986) and PhD(1992) in South Africa. She completed a post-doctoral fellowship at the Clinical Research Institute of Montreal (CRIM) in 1996 and then progressed the scientific/academic ladder. In 2005 she was recruited to the Kidney Research Centre, Ottawa Hospital Research Institute, Univeristy of Ottawa, where she was the Canada Research Chair in Hypertension Tier 1, until 2011 when she was recruited to the University of Glasgow to direct ICAMS. She is an elected Fellow of the Academy of Medical Sciences (FMedSci), the Royal Society of Edinburgh (FRSE), the College of Physicians and Surgeons (FRCP), AHA (FAHA), European Society of Cardiology (FESC) and Canadian Academy of Health Sciences (FCAHS). She has played major leadership roles in the premier national and international hypertension and cardiovascular organisations. She was President of the Canadian Hypertension Society (2007-2008), Chair of the High Blood Pressure Research Council (AHA) (2010-2012), President of the International Society of Hypertension (2014-2016) and President of the European Council for Cardiovascular Research (2019-2021). She was the founder and Chair of the ‘Women in Hypertension Research Network’ of the International Society of Hypertension, the mission of which is to encourage, support and inspire women in science and medicine in the field of hypertension and related cardiovascular diseases and to facilitate new avenues for communication, collaboration and education. She is Editor-in-Chief of Clinical Science, Deputy Editor of Hypertension, and Associate Editor of Pharmacological Reviews. Her research focuses on molecular and vascular mechanisms of hypertension and small vessel disease with a particular interest in i) vascular signaling and redox biology; ii) vascular biology of cations and TRPM channels; iii) cardiovascular oncology, and iv) cardiometabolic and adipose biology. Her recent work explores links between hypertension, vascular injury and COVID-19. Her research spans molecular biology to clinical studies She has published over 535 peer-reviewed papers. She has received numerous prestigious awards, including the Dahl Award (American Heart Association (AHA)), Harriet Dustan Research Award (AHA), Robert M. Berne Distinguished Award (American Physiological Society), Distinguished Scientist Award (Hypertension Canada), RD Wright Award (BP Research Council, Australia), Irvine Page Award (American Society of Hypertension), Joan Mott Award (Physiology Society) and premier international hypertension honor, the Research Excellence Award (Council on Hypertension, AHA). She is also actively involved in contributing to best clinical practice and co-chaired the Canadian Hypertension Education Program for clinical guidelines and is a current member of the Committee for Practice Guidelines of the European Society of Cardiology. She is an inspirational leader and passionate mentor and teacher and has trained over 70 PhD students and fellows, in basic, translational and clinical reaserch. Many of her trainees have gone on to successful independent careers.